A review of pericardial disease highlights the clinical challenges in recognizing and treating pericarditis, pericardial effusions, cardiac tamponade, and constrictive pericarditis.
This review highlights the clinical syndromes of pericardial disease and the challenges in treatment selection due to a lack of randomized controlled trials.
The pericardium is composed of visceral and parietal components. In view of the pericardium's simple structure, pathologic processes involving it are understandably few. However, despite a limited number of clinical syndromes, the pericardium is affected by virtually every category of disease, including infectious, neoplastic, immune-inflammatory, metabolic, iatrogenic, and traumatic. Thus, the recognition of pericardial heart disease remains challenging. Treatment of pericardial disease is also problematic in that there is a paucity of randomized, placebo-controlled trials from which appropriate therapy may be selected and important clinical decisions assisted. This article reviews pericarditis and its sequelae, pericardial effusions, cardiac tamponade and constrictive pericarditis.
Azam et al. (Fri,) conducted a review in Pericardial disease. Treatment of pericardial disease was evaluated. A review of pericardial disease highlights the clinical challenges in recognizing and treating pericarditis, pericardial effusions, cardiac tamponade, and constrictive pericarditis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: